Sightsavers welcomes new Chair of Trustees, Sir Clive Jones CBE

This Wednesday, 10 July 2019, Sir Clive Jones will take the helm of international development charity, Sightsavers’ UK board of trustees.

The reins are passing from the eminent hands of Martin Dinham, who is stepping down from his role after being part of the board for eight years, having chaired it for the last four.

Sir Clive brings with him impressive experience in broadcasting, journalism and humanitarian crisis response.

He is currently chairman of the ITV Pension Fund and Chairman of the Runnymede Trust and National Theatre Wales.

Sir Clive recently received a knighthood for his work as chair of Britain’s Disasters Emergency Committee (DEC) which brings together 14 leading UK aid agencies to raise money at times of humanitarian crises in poorer countries.

Beginning his career as a newspaper journalist, Sir Clive then moved into broadcasting where he held a series of top executive and board roles in the commercial TV sector. Clive has been CEO of a number of the leading ITV companies including Central and the Carlton Television Group and Managing Director of the ITV Network.

Sir Clive said:

“It is privilege to be joining Sightsavers at such an exciting time for the organisation from the real progress that is being made in the elimination of neglected tropical diseases, like blinding trachoma, to supporting countries across Africa and South Asia to strengthen their health care systems and ensure people can get the eye care they need.”

Sightsavers CEO, Caroline Harper said:

“As we welcome Clive into the Sightsavers fold, we also bid a fond a farewell to Martin Dinham, who has led the board of trustees with skill and finesse. Martin has steered us through some momentous moments, including the celebration of the billionth Sightsavers-supported NTD treatment, and a period of sustained growth that has also seen us enhance our work to ensure people with disabilities are included in the development. We look forward to the guidance Clive will provide as we continue our mission to prevent avoidable blindness.”